Gene patent ruling could improve access, patient care

06/13/2013 | CBS News · Medscape (free registration) · HealthDay News

The Supreme Court's decision Thursday to prohibit the patenting of human genes could improve patient care, boost access to genetic testing and cut costs, supporters say. The cost of gene testing will fall and access to second opinions will increase, according to the American Society for Clinical Pathology, one of the plaintiffs in the case. "Because of this ruling, patients will have greater access to genetic testing and scientists can engage in research on these genes without fear of being sued," said Dr. Myra F. Barginear, a New York oncologist.

View Full Article in:

CBS News · Medscape (free registration) · HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA